shutterstock_685347493_katherine_welles
Katherine Welles / Shutterstock.com
25 June 2019Americas

Cancer centre sues BMS and Ono over alleged patent exploitation

Boston-based Dana-Farber Cancer Institute is seeking a share of the $1.6 billion in licensing revenue that BMS and Ono Pharmaceutical Co have allegedly received from six immunotherapy patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
10 September 2014   Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.
Big Pharma
1 March 2022   Japan-based Ono Pharmaceuticals has sued AstraZeneca, accusing the US pharma company of infringing patents covering an antibody used in cancer treatment.

More on this story

Americas
10 September 2014   Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.
Big Pharma
1 March 2022   Japan-based Ono Pharmaceuticals has sued AstraZeneca, accusing the US pharma company of infringing patents covering an antibody used in cancer treatment.

More on this story

Americas
10 September 2014   Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.
Big Pharma
1 March 2022   Japan-based Ono Pharmaceuticals has sued AstraZeneca, accusing the US pharma company of infringing patents covering an antibody used in cancer treatment.